Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema

A Multicenter, Open Uncontrolled Clinical Study to Examine the Efficacy and Safety of Zarzenda in the Management of Hand Eczema

To show efficacy of Zarzenda in the treatment of hand eczema

The objective of the study is to demonstrate efficacy and safety of Zarzenda (a medical device) in the management of hand eczema.

Inclusion Criteria:

• Mild to moderate hand eczema for at least 3 months
• At least 4 weeks have passed since use of systemic treatment for eczema
• At least 4 weeks have passed since any vaccination
• At least 1 week has passed since last topic treatment on hands with corticosteroids
• Agree to use adequate contraceptive method if of childbearing potential
• Willingness to avoid excessive exposure to sunlight and avoid skin irritants

Exclusion Criteria:

• Pregnancy, breast feeding
• Severe excoriations on the hands
• Need for systemic treatment for atopic dermatitis
• Known sensitivity to Zarzenda and/or to extract of nut butyrospermum parkii (shea)
• Known immune deficiency
• Concomitant infection on hands